HM
BHVN

Harvest Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Harvest Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-48,503
Closed -$7.33M – 89
2022
Q3 		$7.33M Buy
48,503
+6,900
+17% +$1.02M 5.92% 3
2022
Q2 		$6.06M Buy
41,603
+38,970
+1,480% +$4.98M 7% 3
2022
Q1 		$312K Sell
2,633
-17
-0.6% -$2.12K 0.27% 45
2021
Q4 		$365K Buy
2,650
+250
+10% +$31.8K 0.21% 43
2021
Q3 		$333K Buy
2,400
+200
+9% +$25K 0.23% 49
2021
Q2 		$214K Buy
+2,200
New +$179K 0.14% 44
2020
Q1 		– Sell
-4,721
Closed -$257K – 68
2019
Q4 		$257K Sell
4,721
-1,279
-21% -$63.3K 0.51% 38
2019
Q3 		$250K Sell
6,000
-3,900
-39% -$165K 0.35% 40
2019
Q2 		$434K Buy
+9,900
New +$558K 0.6% 32

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $403M AUM 28.73% 1-Year Est. Return

Harvest Management's BHVN Position: Q4 2022 in Review

Harvest Management sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 48,503 shares — an estimated $7.33M sold.

Harvest Management first reported a position in BHVN in Q2 2019 and held it in 9 quarters. The position peaked at $7.33M in Q3 2022. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Harvest Management reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Harvest Management sold 48,503 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $7.33M.
  • Harvest Management first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2019 and held it in 9 quarters.
  • Harvest Management's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $7.33M in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Harvest Management's 13F filing for Q4 2022, filed 14 Feb 2023.